Core Insights - The domestic energy storage and battery market is experiencing significant growth, with May's installed capacity reaching 23.1 GWh, reflecting a year-on-year increase of 679% and a month-on-month increase of 427% [1] - The sales of energy storage and other batteries in May reached 36 GWh, with a year-on-year increase of 69% and a month-on-month increase of 15% [1] - The lithium battery sector is seeing price declines, with lithium carbonate priced at 59,600 CNY/ton, down 7% from the previous month, and lithium hydroxide at 62,400 CNY/ton, down 5% [1] Industry Changes - The solid-state battery technology is transitioning from pilot production to mass production, with key companies receiving MWh scale orders and planning GWh scale production lines [1][6] - The solid-state battery is expected to enter the vehicle testing phase between 2026 and 2027, marking a significant technological advancement in the industry [3] - The overall performance of the lithium battery sector has been active since June 2025, with over half of the segments outperforming major indices [2] Market Trends - The sales of new energy vehicles in May reached 1.22 million units in China, showing a year-on-year increase of 33% and a month-on-month increase of 17% [1][4] - The cumulative sales of new energy vehicles from January to May reached 4.98 million units, reflecting a year-on-year increase of 41% [1] - The market for energy storage in China is driven by the "531 installation rush," leading to a significant increase in installed capacity [4] Investment Recommendations - The lithium battery sector is expected to shift from broad market-driven growth to structural opportunities led by technological breakthroughs and new application fields in 2025 [7] - Key companies recommended for investment include CATL, EVE Energy, Keda Industrial, and Xiamen Tungsten [7]

Group 1 - The core point of the news is that Yunnan Daye Shengde Enterprise Management Co., Ltd. plans to reduce its holdings in Keda Li (002850.SZ) by up to 3,824,933 shares, which represents 1.3985% of the company's total share capital, without causing a change in actual control [1] - Keda Li's major shareholders, Li Jili and Li Jianju, will continue to hold 102,163,386 shares, accounting for 37.3532% of the total share capital after the reduction [1] - Keda Li was listed on March 2, 2017, with an initial issuance price of 37.70 yuan per share, raising a total of 1,319.50 million yuan [1] Group 2 - The company was approved to issue up to 40 million shares through a private placement, ultimately issuing 22,920,451 shares at an issuance price of 60.47 yuan per share, raising approximately 1,385.99 million yuan [2] - After deducting underwriting and other fees, the net proceeds from this issuance amounted to approximately 1,360.36 million yuan [2] - The company issued 15,343,705 convertible bonds with a total fundraising amount of 1,534.37 million yuan, with net proceeds of approximately 1,515.10 million yuan after deducting fees [3] Group 3 - The company received approval to issue 33,471,626 shares to specific investors, raising a total of approximately 3,509.50 million yuan, with net proceeds of about 3,480.12 million yuan after deducting issuance costs [4] - The total amount raised by Keda Li through four fundraising activities is approximately 774.94 million yuan [5]

| 证券代码：002850 | 证券简称：科达利 | 公告编号：2025-043 | | --- | --- | --- | | 债券代码：127066 | 债券简称：科利转债 | | 深圳市科达利实业股份有限公司 关于 2025 年第二季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管 指引第 15 号——可转换公司债券》的有关规定，深圳市科达利实业股份有限公 司（以下简称"公司"）就 2025 年第二季度可转换公司债券转股情况及公司股本 变动情况公告如下： 一、可转换公司债券发行上市情况 （一）可转债发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于核准深圳市 科达利实业股份有限公司公开发行可转换公司债券的批复》（证监许可〔2022〕 1143 号）核准，公司于 2022 年 7 月 8 日公开发行可转换公司债券（以下简称"本 次发行"）15,343,705 张，每张面值为人民币 100 元，期限 6 年，募集资金总额 为人民币 153,4 ...

Group 1 - Kanghong Pharmaceutical received a drug registration certificate for Lifisig Eye Drops, approved for treating dry eye symptoms [1] - Kanghong Biotech, a wholly-owned subsidiary, received clinical trial approval for KH813 injection for metastatic non-squamous non-small cell lung cancer [1] - Kanghong Pharmaceutical was established in October 1996, focusing on drug and medical device research, production, and sales [1] Group 2 - Guoyuyuan's subsidiary received a government subsidy of 7.5521 million yuan, accounting for 10.14% of the company's audited net profit for 2024 [2] - Guoyuyuan was founded in November 1996, specializing in drug research, production, and sales [3] Group 3 - Haicheng Bonda's subsidiary signed a lease termination agreement, incurring a termination fee of 3.35 million USD [4] - Haicheng Bonda was established in December 2009, providing comprehensive modern logistics services [4] Group 4 - Hongxin Electronics' subsidiary signed contracts totaling 373 million yuan for computing power business [5] - Hongxin Electronics was founded in September 2003, focusing on FPC research, design, manufacturing, and sales [6] Group 5 - Tianbang Food reached a settlement agreement regarding a 1.214 billion yuan lawsuit, agreeing to repay 410 million yuan over 36 months [8] - Tianbang Food was established in September 1996, specializing in pig farming and pork processing [9] Group 6 - Daoshi Technology's controlling shareholder plans to reduce holdings by up to 1.97% of the company's shares [10] - Daoshi Technology was founded in September 2007, focusing on ceramic color glazes and related products [10] Group 7 - Jinpu Titanium is planning a major asset restructuring, leading to a stock suspension [10] - Jinpu Titanium was established in November 1989, specializing in titanium dioxide production and sales [11] Group 8 - Shenzhen Energy plans to invest 6.332 billion yuan in upgrading the Mawan Power Plant [12] - Shenzhen Energy was founded in August 1993, focusing on conventional and renewable energy development [13] Group 9 - Lihua Co. plans to reduce holdings by up to 3% of the company's shares [14] - Lihua Co. was established in June 1997, specializing in the breeding and sales of poultry [15] Group 10 - China Communications Construction Company plans to repurchase shares worth 500 million to 1 billion yuan [16] - China Communications Construction Company was founded in October 2006, focusing on infrastructure design and construction [17] Group 11 - Huatiankeji's subsidiary received a government subsidy of 80.6569 million yuan, accounting for 13.09% of the company's latest audited net profit [20] - Huatiankeji was established in December 2003, specializing in integrated circuit packaging and testing [21] Group 12 - Luxin Chuangtou plans to acquire shares in Hongke Electronics for a total of 9 million yuan [23] - Luxin Chuangtou was founded in November 1993, focusing on venture capital and industrial development [24] Group 13 - Feilong Co.'s controlling shareholder plans to reduce holdings by up to 563,250 shares [25] - Feilong Co. was established in January 2001, specializing in thermal management components for automotive and civil applications [26] Group 14 - Linglong Tire submitted an application for H-share listing on the Hong Kong Stock Exchange [27] - Linglong Tire was founded in June 1994, focusing on tire design, development, manufacturing, and sales [27] Group 15 - Saiwei Electronics plans to acquire 9.5% of its subsidiary's shares for up to 324 million yuan [28] - Saiwei Electronics was established in May 2008, focusing on MEMS chip development and semiconductor equipment [28] Group 16 - Suzhou Bank's major shareholder plans to increase holdings by no less than 400 million yuan [29] - Suzhou Bank was founded in December 2004, focusing on various banking services [29]

Group 1 - Aike Cyber (688719.SH) shareholders Dachen Chuangtong and Dachen Chuanghong reduced their holdings by 2,298,151 shares, accounting for 1.99% of the total share capital, and did not complete the planned reduction [1] - Benchuan Intelligent (300964.SZ) controlling shareholder Dong Xiaojun reduced his holdings by 355,787 shares, accounting for 0.4582% of the total share capital, bringing his shareholding down to 21.64% [1] - Changlian Co., Ltd. (603648.SH) completed its reduction plan by selling 3,624,050 shares, which is 1% of the total share capital [1] Group 2 - Chuan Yi Technology (002866.SZ) controlling shareholder Zou Weimin and his concerted party reduced their holdings, with Zou's shareholding dropping to 48.53% [2] - Daoshi Technology (300409.SZ) controlling shareholder Rong Jihua plans to reduce his holdings by up to 15,416,611 shares, accounting for 1.97% of the total share capital [2] - Electric Alloy (300697.SZ) completed its reduction plan by selling 2,741,390 shares, which is 0.63% of the total share capital [2] Group 3 - Fujirei (688272.SH) shareholders Suzhou Kongkong, Suzhou Zhaorong, and Shanghai Zhaoren reduced their holdings by 1,215,618 shares, 1,463,490 shares, and 44,944 shares, accounting for 1.60%, 1.93%, and 0.06% of the total share capital respectively [3] - Gaoweida (300465.SZ) controlling shareholder Yingtan Yinggao Investment Consulting Co., Ltd. reduced its holdings by 4,261,700 shares, accounting for 0.96% of the total share capital, bringing its shareholding down to 22.00% [3] - Haizheng Materials (688203.SH) shareholder Sinopec Capital plans to reduce its holdings by up to 3,525,600 shares, accounting for 1.74% of the total share capital [3] Group 4 - Hangyu Micro (300053.SZ) shareholder Yan Jun reduced his holdings by 3,930,000 shares, accounting for 0.56% of the total share capital [4] - He Shi Eye Hospital (301103.SZ) shareholder Advanced Manufacturing Industry Investment Fund plans to reduce its holdings by up to 3,106,074 shares, accounting for 2% of the total share capital [4] - He Yuan Gas (002971.SZ) shareholder Baishide Chuangye completed its reduction plan by selling 854,064 shares, which is 0.415% of the total share capital [4] Group 5 - Huaren Health (301408.SZ) shareholder Saifu Investment reduced its holdings by 2,107,696 shares, accounting for 0.53% of the total share capital [5] - Jiangsu Boyun (301003.SZ) shareholder Gong Wei reduced his holdings by 1,558,900 shares, accounting for 1.57% of the total share capital [5] - Jeya Co., Ltd. (301108.SZ) shareholders Mingyuan Fund and its concerted party did not reduce their holdings, and the reduction plan period expired [5] Group 6 - Longxin General (603766.SH) directors plan to reduce their holdings by up to 350,000 shares and 100,000 shares, accounting for 0.0170% and 0.0049% of the total share capital respectively [6] - Ruchuang Micro-Nano (688002.SH) shareholder Li Weicheng plans to reduce his holdings by up to 8,000,000 shares, accounting for 1.75% of the total share capital [6] - Shilan Micro (600460.SH) shareholder Luo Huabing plans to reduce his holdings by up to 500,000 shares, accounting for 0.03005% of the total share capital [6] Group 7 - Tongfu Microelectronics (002156.SZ) shareholder National Integrated Circuit Industry Investment Fund reduced its holdings by 15,175,969 shares, accounting for 1% of the total share capital [7] - Wangzi New Materials (002735.SZ) controlling shareholder Wang Jinjun reduced his holdings by 9,717,874 shares, accounting for 2.54% of the total share capital [7] - Xingye Co., Ltd. (603928.SH) shareholder Shen Genzhen reduced his holdings by 2,620,000 shares, accounting for 1.00% of the total share capital [7] Group 8 - Yikang Co., Ltd. (301085.SZ) controlling shareholder concerted party reduced its holdings by 633,700 shares, accounting for 0.73% of the total share capital [8] Group 9 - Yiming Pharmaceutical (002826.SZ) major shareholder Zhou Zhan reduced his holdings by 3,586,777 shares, accounting for 1.88% of the total share capital [9] - Yiming Pharmaceutical (002826.SZ) director Xi Ke reduced his holdings by 283,862 shares, accounting for 0.15% of the total share capital [9] - Youyan Powder Materials (688456.SH) concerted party reduced its holdings by 1,030,000 shares, accounting for 0.99% of the total share capital [9] Group 10 - Zhongma Transmission (603767.SH) directors plan to reduce their holdings through block trading and centralized bidding [10] - Zhongqi Co., Ltd. (301215.SZ) shareholder Jiangsu Yueda Group did not reduce its holdings, and the reduction plan period expired [10]

Group 1 - The main point of the announcement is that Yunnan Daye Shengde Enterprise Management Co., Ltd. plans to reduce its shareholding in Keda Li Industrial Co., Ltd. by up to 3,824,933 shares, which represents 1.3985% of the total share capital, through block trading within a specified period [1][2] - The reduction period is set from July 23, 2025, to October 22, 2025, excluding any legally prohibited reduction periods [2] - The reason for the reduction is stated as the shareholder's own funding needs [2] Group 2 - Yunnan Daye Shengde currently holds 3,824,933 shares, accounting for 1.3985% of the total share capital of Keda Li [2] - The shares to be reduced are sourced from shares acquired before the company's initial public offering and from the 2017 annual equity distribution [2] - The reduction will be conducted at market prices during the implementation period [2] Group 3 - The shareholder has made commitments regarding the transfer of shares, including a lock-up period of 36 months from the company's listing date, which has now expired [3] - The shareholder has fulfilled the commitments made previously, and the current reduction plan is consistent with prior disclosures [3] - The plan does not violate any relevant laws or regulations, ensuring compliance with the legal framework governing share reductions [5]

科达利(002850.SZ)公告称，大业盛德计划自本公告披露之日起15个交易日后的3个月内以大宗交易的方 式减持公司股份不超过3,824,933股，占公司总股本比例1.3985%。 ...

关于股东减持股份预披露公告 公司股东云南大业盛德企业管理有限公司保证向本公司提供的信息内容真实 、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 | 证券代码：002850 | 证券简称：科达利 | 公告编号：2025-042 | | --- | --- | --- | | 债券代码：127066 | 债券简称：科利转债 | | 深圳市科达利实业股份有限公司 特别提示： 持有深圳市科达利实业股份有限公司（以下简称"公司"或"本公司"）股 份 3,824,933 股（占公司总股本比例 1.3985%）的云南大业盛德企业管理有限公 司（以下简称"大业盛德"）计划自本公告披露之日起 15 个交易日后的 3 个月 内（即从 2025 年 7 月 23 日起至 2025 年 10 月 22 日止，根据法律法规禁止减 持的期间除外）以大宗交易的方式减持公司股份不超过 3,824,933 股（占公司 总股本比例 1.3985%）。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 大业盛德为公司控股股东/实际控制人励建立先生、励建炬先生的一致行动 人，本次减持股份完成后，励建立先生、励建炬先生仍持有公司 ...

特别提示： 1、"科利转债"将于 2025 年 7 月 8 日按面值支付第三年利息，每 10 张"科 利转债"（面值 1,000.00 元）利息为人民币 10.00 元（含税）。 2、债权登记日：2025 年 7 月 7 日 关于可转换公司债券 2025 年付息的公告 3、除息日：2025 年 7 月 8 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 4、付息日：2025 年 7 月 8 日 | 证券代码：002850 | 证券简称：科达利 | 公告编号：2025-037 | | --- | --- | --- | | 债券代码：127066 | 债券简称：科利转债 | | 深圳市科达利实业股份有限公司 5、"科利转债"票面利率：第一年 0.30%、第二年 0.50%、第三年 1.00%、 第四年 1.50%、第五年 1.80%、第六年 2.00%。 6、"科利转债"本次付息的债权登记日为 2025 年 7 月 7 日，凡在 2025 年 7 月 7 日（含）前买入并持有本期债券的投资者享有本次派发的利息；2025 年 7 月 7 日卖出本期债券的投资者 ...

中国国际金融股份有限公司 关于深圳市科达利实业股份有限公司 将部分募集资金借款转为对全资子公司增资的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为 深圳市科达利实业股份有限公司（以下简称"科达利"或"公司"）2023 年向 特定对象发行股票项目的保荐机构，根据《上市公司募集资金监管规则》《深圳 证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》等有关规定，对公司将部分募集资金借款转为对全资子 公司增资的事项进行核查，核查情况及核查意见如下： 一、 募集资金基本情况 经中国证券监督管理委员会《关于同意深圳市科达利实业股份有限公司向特 定对象发行股票注册的批复》（证监许可〔2023〕1356 号）注册批复，由主承销 商中金公司通过向特定投资者发行股票方式，向特定对象发行人民币普通股股票 33,471,626 股，募集资金总额人民币 3,509,499,986.10 元，扣除不含税的发行费 用人民币 29,382,955.91 元，实际募集资金净额为人民币 3,480,117,030.19 元，已 由主承销商中金公司于 2023 年 7 ...